Rabbit Recombinant Multiclonal ALK phospho Y1278 + Y1507 + Y1604 antibody. Suitable for Dot, WB, IP and reacts with Synthetic peptide - Human, Human samples.
IgG
Rabbit
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Liquid
Multiclonal
Dot | WB | IP | IHC-P | |
---|---|---|---|---|
Human | Expected | Tested | Tested | Not recommended |
Mouse | Not recommended | Not recommended | Not recommended | Not recommended |
Rat | Not recommended | Not recommended | Not recommended | Not recommended |
Synthetic peptide - Human | Tested | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/30 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide - Human | Dilution info - | Notes - |
Neuronal receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system. Transduces signals from ligands at the cell surface, through specific activation of the mitogen-activated protein kinase (MAPK) pathway. Phosphorylates almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif. Following activation by ligand, ALK induces tyrosine phosphorylation of CBL, FRS2, IRS1 and SHC1, as well as of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Acts as a receptor for ligands pleiotrophin (PTN), a secreted growth factor, and midkine (MDK), a PTN-related factor, thus participating in PTN and MDK signal transduction. PTN-binding induces MAPK pathway activation, which is important for the anti-apoptotic signaling of PTN and regulation of cell proliferation. MDK-binding induces phosphorylation of the ALK target insulin receptor substrate (IRS1), activates mitogen-activated protein kinases (MAPKs) and PI3-kinase, resulting also in cell proliferation induction. Drives NF-kappa-B activation, probably through IRS1 and the activation of the AKT serine/threonine kinase. Recruitment of IRS1 to activated ALK and the activation of NF-kappa-B are essential for the autocrine growth and survival signaling of MDK. Thinness gene involved in the resistance to weight gain: in hypothalamic neurons, controls energy expenditure acting as a negative regulator of white adipose tissue lipolysis and sympathetic tone to fine-tune energy homeostasis (By similarity).
ALK phospho Y1278, ALK phospho Y1507, ALK
ALK tyrosine kinase receptor, Anaplastic lymphoma kinase
Rabbit Recombinant Multiclonal ALK phospho Y1278 + Y1507 + Y1604 antibody. Suitable for Dot, WB, IP and reacts with Synthetic peptide - Human, Human samples.
IgG
Rabbit
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Liquid
Multiclonal
RM1164
Affinity purification Protein A
Blue Ice
1-2 weeks
+4°C
-20°C
Upon delivery aliquot
Avoid freeze / thaw cycle
This product is a recombinant multiclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This supplementary information is collated from multiple sources and compiled automatically.
The Anaplastic Lymphoma Kinase commonly referred to as ALK is a receptor tyrosine kinase known for its role in cell signaling. It is sometimes called CD246. ALK has a molecular mass of approximately 180 kDa. This protein finds expression predominantly in the central and peripheral nervous system with prominence in neural tissue during development. The ALK protein belongs to the insulin receptor superfamily exhibiting kinase activity that promotes signal transduction processes associated with growth and differentiation.
ALK influences cell growth survival and differentiation playing a significant role during the development of the nervous system. As part of its biological activity the ALK protein can become a component of larger signaling complexes participating as an important activator or mediator. Evidence suggests ALK's involvement in neuronal differentiation and synaptogenesis. Its activity impacts intracellular pathways consequently modulating biological processes relevant to neural tissue and oncogenesis.
ALK acts within the MAPK and PI3K-AKT signaling pathways. These pathways enable the transduction of signals from the cell surface to the nucleus influencing cellular outcomes such as proliferation and survival. In these pathways ALK interacts with various other proteins including GRB2 and PI3K which further facilitate downstream signaling. Proper functioning of these pathways is essential to maintaining cellular homeostasis and development.
ALK has a significant relationship with certain types of cancer such as non-small cell lung carcinoma and anaplastic large cell lymphoma. Genetic alterations in ALK such as translocations or mutations can lead to the uncontrolled activation of its kinase activity resulting in oncogenic transformation. In these contexts the ALK protein often interacts with EML4 in lung cancer through a fusion forming an oncogenic driver. Targeting ALK with anti-ALK antibodies or small molecule inhibitors has emerged as a therapeutic strategy to manage these malignancies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Dot blot analysis of ALK (phospho Y1278 + Y1507 + Y1604) using ab322000 at 1:1000 dilution (0.476 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1:100,000 dilution.
Lane1: Human ALK tyrosine kinase receptor (phospho Y1604) peptide (aa1600-1609)
Lane2: Human ALK tyrosine kinase receptor peptide (aa1599-1610)
Lane3: Human ALK tyrosine kinase receptor (phospho Y1507) peptide (aa1501-1516)
Lane4: Human ALK tyrosine kinase receptor peptide (aa1500-1516)
Lane5: Human ALK tyrosine kinase receptor (phospho Y1278) peptide (aa1272-1284)
Lane6: Human ALK tyrosine kinase receptor peptide (aa1272-1284)
Lane7: Human ALK tyrosine kinase receptor (phospho Y1282) peptide (aa1272-1286)
Lane8: Human ALK tyrosine kinase receptor (phospho Y1283) peptide (aa1272-1286)
Lane9: Human ALK tyrosine kinase receptor (phospho Y1282+Y1283) peptide (aa1272-1286)
Exposure time: 180 seconds.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
All lanes: Dot Blot - Anti-ALK (phospho Y1278 + Y1507 + Y1604) antibody [RM1164] (ab322000) at 1/1000 dilution
Lane 1: Human ALK tyrosine kinase receptor (phospho Y1604) peptide (aa1600-1609)
Lane 2: Human ALK tyrosine kinase receptor peptide (aa1599-1610)
Lane 3: Human ALK tyrosine kinase receptor (phospho Y1507) peptide (aa1501-1516)
Lane 4: Human ALK tyrosine kinase receptor peptide (aa1500-1516)
Lane 5: Human ALK tyrosine kinase receptor (phospho Y1278) peptide (aa1272-1284)
Lane 6: Human ALK tyrosine kinase receptor peptide (aa1272-1284)
Lane 7: Human ALK tyrosine kinase receptor (phospho Y1282) peptide (aa1272-1286)
Lane 8: Human ALK tyrosine kinase receptor (phospho Y1283) peptide (aa1272-1286)
Lane 9: Human ALK tyrosine kinase receptor (phospho Y1282+Y1283) peptide (aa1272-1286)
All lanes: Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Exposure time: 180s
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
KARPAS-299 cells carry the NPM-ALK fusion (PMID: 32193476, PMID: 9736036).
Phosphorylated Tyr338/ Tyr567/ Tyr664 of NPM-ALK is equivalent to Tyr1278/ Tyr1507/ Tyr1604 of full length ALK (PMID: 19887368).
Bands around 300 kDa may be due to protein aggregation (PMID: 9121481).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
In Western blot, Anti-ALK antibody [SP144] (Anti-ALK antibody [SP144] ab183332) staining at 1/1000 dilution.
All lanes: Western blot - Anti-ALK (phospho Y1278 + Y1507 + Y1604) antibody [RM1164] (ab322000) at 1/1000 dilution
Lane 1: Untreated KARPAS-299 (human anaplastic large cell lymphoma) whole cell lysate at 20 µg
Lane 2: KARPAS-299 treated with 1 uM Crizotinib for 1 hour whole cell lysate, whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 80 kDa, 300 kDa, 36 kDa
Exposure time: 180s
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
KARPAS-299 cells carry the NPM-ALK fusion (PMID: 32193476, PMID: 9736036).
Phosphorylated Tyr338/ Tyr567/ Tyr664 of NPM-ALK is equivalent to Tyr1278/ Tyr1507/ Tyr1604 of full length ALK (PMID: 19887368).
Bands around 300 kDa may be due to protein aggregation (PMID: 9121481).
Lysates were prepared from fresh material and used for Western blotting immediately to minimize protein degradation.
In Western blot, Anti-ALK antibody [SP144] (Anti-ALK antibody [SP144] ab183332) staining at 1/1000 dilution.
All lanes: Western blot - Anti-ALK (phospho Y1278 + Y1507 + Y1604) antibody [RM1164] (ab322000) at 1/1000 dilution
Lane 1: KARPAS-299 (human anaplastic large cell lymphoma), whole cell lysate (Untreated membrane) at 20 µg
Lane 2: KARPAS-299 whole cell lysate (phosphatase treated membrane) at 20 µg
Lane 3: KARPAS-299 treated with 50 uM pervanadate for 30 minutes, whole cell lysate (Untreated membrane) at 20 µg
Lane 4: KARPAS-299 treated with 50 uM pervanadate for 30 minutes, whole cell lysate (phosphatase treated membrane) at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 80 kDa, 300 kDa
Exposure time: 59s
ALK (phospho Y1278 + Y1507 + Y1604) was immunoprecipitated from 0.35 mg KARPAS-299 (human T cell lymphoma cell) whole cell lysate with ab322000 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab322000 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: KARPAS-299 (human T cell lymphoma cell) whole cell lysate
Lane 2: ab322000 IP in KARPAS-299 (human T cell lymphoma cell) whole cell lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab322000 in KARPAS-299 whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST
All lanes: Immunoprecipitation - Anti-ALK (phospho Y1278 + Y1507 + Y1604) antibody [RM1164] (ab322000) at 1/30 dilution
All lanes: KARPAS-299 (human T cell lymphoma cell) whole cell lysate
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution
Exposure time: 3s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com